UBS Adjusts Price Target on Pershing Square to $44 From $39, Maintains Neutral Rating

UBS raised its price target for Pershing Square from $39 to $44 while keeping a neutral rating. The stock is currently trading at $45.42, up 0.85% on the day and year.

Original reporting
Published Oct 23, 2026, 1:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 2:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$PS
Relevance
4/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

Low
01

Why it matters

The adjustment reflects UBS's view on Pershing Square's valuation but does not affect any publicly traded security.

02

Market read

Limited relevance to public markets; no tradable ticker is directly impacted.

03

What to watch

Pershing Square is a private hedge fund; the target change may have limited market impact.

Relevance 4/10Novelty 3/10Timing: today

Background

UBS revised its price target for Pershing Square, a private hedge fund, from $39 to $44 while keeping a neutral rating.

Market effects

None

None

None

Counterpoint

No contrarian angle evident.

Key entities

  • UBS

    Investment bank providing the price target update.

  • Pershing Square

    Private investment vehicle for which the price target was changed.

Related articles

$PSHigh

Ackman's Pershing Square Stock Falls as BofA Turns Bearish

Pershing Square (PS) dropped 11.62% after BofA downgraded it to Underperform and lowered its price target to $38 from $54. BofA cited underperformance in 2026 and a portfolio misalignment with current market leaders. The firm's net asset value is down 8% year-to-date, underperforming the S&P 500's 15% gain. Key holdings include Uber, Brookfield, Microsoft, Amazon, and Meta.

$PSHMedAI 8/10

Pershing Square Sinks 12% on Second Downgrade in Two Days as BofA Cuts Target to $38

Pershing Square (PS) shares dropped 12% after BofA downgraded it to Underperform and cut its price target to $38 from $54, citing delayed PSV launch and reduced growth expectations. Citi also downgraded the stock to Sell, noting flat earnings estimates since its April IPO. The company's flagship fund's NAV fell 12.6% in H1 2026, underperforming the S&P 500's 10.2% gain.

$CMed

Crude Oil Edges Higher; Citigroup Earnings Top Views

Citigroup (NYSE:C) reported Q3 earnings of $2.85 per share, beating estimates. Bumble (NASDAQ:BMBL) surged 56% after a buyout deal. BIO-Key (NASDAQ:BKYI) rose 139% on a government security contract. Fermi (NASDAQ:FRMI) gained 21% on a credit agreement. Pershing Square (NYSE:PS) fell 11% after a downgrade. Cipher Digital (NASDAQ:CIFR) dropped 14% on a convertible notes offering. Syndax (NASDAQ:SNDX) declined 17% after a trial failure. Oil rose 0.4% to $94.13, while gold and silver fell.